GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » Return-on-Tangible-Asset

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Return-on-Tangible-Asset : -5.10% (As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is BlackRock Health Sciences Trust II Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. BlackRock Health Sciences Trust II's annualized Net Income for the quarter that ended in Dec. 2023 was $-104.80 Mil. BlackRock Health Sciences Trust II's average total tangible assets for the quarter that ended in Dec. 2023 was $2,054.51 Mil. Therefore, BlackRock Health Sciences Trust II's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was -5.10%.

The historical rank and industry rank for BlackRock Health Sciences Trust II's Return-on-Tangible-Asset or its related term are showing as below:

BMEZ' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -26.75   Med: -2.66   Max: 36.98
Current: 3.38

During the past 4 years, BlackRock Health Sciences Trust II's highest Return-on-Tangible-Asset was 36.98%. The lowest was -26.75%. And the median was -2.66%.

BMEZ's Return-on-Tangible-Asset is ranked better than
53.5% of 1716 companies
in the Asset Management industry
Industry Median: 2.735 vs BMEZ: 3.38

BlackRock Health Sciences Trust II Return-on-Tangible-Asset Historical Data

The historical data trend for BlackRock Health Sciences Trust II's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BlackRock Health Sciences Trust II Return-on-Tangible-Asset Chart

BlackRock Health Sciences Trust II Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
36.98 -8.77 -26.75 3.46

BlackRock Health Sciences Trust II Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial -20.99 -58.40 6.81 11.53 -5.10

Competitive Comparison of BlackRock Health Sciences Trust II's Return-on-Tangible-Asset

For the Asset Management subindustry, BlackRock Health Sciences Trust II's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BlackRock Health Sciences Trust II's Return-on-Tangible-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Trust II's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Trust II's Return-on-Tangible-Asset falls into.



BlackRock Health Sciences Trust II Return-on-Tangible-Asset Calculation

BlackRock Health Sciences Trust II's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=69.859/( (2085.822+1954.072)/ 2 )
=69.859/2019.947
=3.46 %

BlackRock Health Sciences Trust II's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-104.798/( (2154.956+1954.072)/ 2 )
=-104.798/2054.514
=-5.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


BlackRock Health Sciences Trust II  (NYSE:BMEZ) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


BlackRock Health Sciences Trust II Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
BlackRock Health Sciences Trust II is a closed-end management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Frank Fabozzi director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212